Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Generative Artificial Intelligence (AI) In Drug Discovery Global Market Report 2025
Request Sample Buy Now
Global Generative Artificial Intelligence (AI) In Drug Discovery Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Generative Artificial Intelligence (AI) In Drug Discovery Global Market Report 2025

By Type (Small Molecule, Large Molecule), By Technology (Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing), By End-User (Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

• Generative Artificial Intelligence (AI) In Drug Discovery market size has reached to $0.19 billion in 2024

• Expected to grow to $0.7 billion in 2029 at a compound annual growth rate (CAGR) of 28.8%

• Growth Driver: Rising Clinical Trials on the Generative AI in Drug Discovery Market

• Market Trend: Advanced AI Solutions To Revolutionize Drug Discovery And Precision Medicine

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Generative Artificial Intelligence (AI) In Drug Discovery Market?

Generative AI in drug discovery involves using advanced machine learning, especially generative models, to create and identify new pharmaceutical compounds. These AI systems analyze extensive data, including chemical properties, biological activity, and existing drug information to predict and generate novel molecules with potential therapeutic benefits. The primary aim of generative AI in drug discovery is to accelerate the creation and identification of novel pharmaceutical compounds with potential therapeutic effects, optimizing the drug development process by leveraging extensive data to predict and generate new molecules efficiently.

The main types of generative artificial intelligence (AI) in drug discovery are Small Molecule and large molecule. The small molecules are drugs that are chemically synthesized and typically have a low molecular weight. The technologies include deep learning, machine learning, reinforcement learning, molecular docking, and quantum computing are used by various end-users including pharmaceutical and biotechnology companies, academic and research institutions, contract research organizations (CROs), and others.

Generative Artificial Intelligence (AI) In Drug Discovery Market Size and growth rate 2025 to 2029: Graph

What Is The Generative Artificial Intelligence (AI) In Drug Discovery Market Size 2025 And Growth Rate?

The generative artificial intelligence (AI) in drug discovery market size has grown exponentially in recent years. It will grow from $0.19 billion in 2024 to $0.25 billion in 2025 at a compound annual growth rate (CAGR) of 30.6%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, development of new drug discoveries and clinical trials, supporting AI integration into healthcare and drug development, growing biotech industries and increasing governmental support.

What Is The Generative Artificial Intelligence (AI) In Drug Discovery Market Growth Forecast?

The generative artificial intelligence (AI) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to $0.7 billion in 2029 at a compound annual growth rate (CAGR) of 28.8%. The growth in the forecast period can be attributed to demand for cost-effective drug discovery drives adoption of generative AI, growing collaborations among market players, increasing computational power, integration of generative AI with other emerging technologies and rapid drug development. Major trends in the forecast period include advanced technologies, integration of generative AI with experimental biology, high-throughput screening for accelerated drug discovery pipelines, development of AI-driven platforms for drug repurposing and rising adoption of cloud-based AI solutions for collaborative drug discovery efforts.

The forecast of 28.8% growth over the next five years reflects a modest reduction of 0.6% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. pharmaceutical industry by increasing the cost of Artificial intelligence(AI)-based molecular modeling platforms sourced from the UK and France, thereby slowing novel drug development and elevating research and development (R&D) investment requirements. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

How Is The Generative Artificial Intelligence (AI) In Drug Discovery Market Segmented?

1) By Type: Small Molecule, Large Molecule

2) By Technology: Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing

3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users

Subsegments:

1) By Small Molecule: Drug Design And Optimization, Lead Discovery And Identification, Toxicology Prediction, Molecular Property Prediction, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction

2) By Large Molecule: Protein Structure Prediction, Antibody Design, Biologics Optimization, Peptide Design, Biopharmaceutical Discovery And Optimization

What Is Driving The Generative Artificial Intelligence (AI) In Drug Discovery Market? Rising Clinical Trials on the Generative AI in Drug Discovery Market

The rising number of clinical trials is expected to propel the growth of generative AI in the drug discovery market. Clinical trials involve human volunteers and assess the safety and effectiveness of new medical treatments or procedures, aiming to gather scientific data on their suitability for human use. The rising number of clinical trials is primarily attributed to advancements in medical research, increased disease burden, regulatory changes, globalization of clinical research, patient advocacy and awareness, industry competition, technological advancements, and funding opportunities. Clinical trial data fuels generative AI models, expediting drug discovery by predicting interactions and designing compounds. This synergy enables personalized medicine, optimizes treatment efficacy, improves patient outcomes, and revolutionizes the pharmaceutical landscape. For instance, according to ClinicalTrials.gov, a US-based clinical trial registry, by the end of 2023, there were 477,234 clinical trials registered globally, marking an increase from the 437,512 trials registered in 2022. Therefore, the rising number of clinical trials is driving the growth of generative AI in the drug discovery market.

Who Are The Major Players In The Global Generative Artificial Intelligence (AI) In Drug Discovery Market?

Major companies operating in the generative artificial intelligence (AI) in drug discovery market are Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrödinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc

What Are The Key Trends Of The Global Generative Artificial Intelligence (AI) In Drug Discovery Market? Advanced AI Solutions To Revolutionize Drug Discovery And Precision Medicine

Major companies operating in the generative AI in the drug discovery market are developing advanced AI-powered tools to accelerate drug discovery processes. AI-powered tools accelerate drug development by streamlining drug discovery, design, and clinical trials through predictive analytics and machine learning. They enhance efficiency in target identification and compound screening such as virtual screening using AI, preclinical development, regulatory compliance, and manufacturing processes. For instance, in May 2023, Google Cloud, a US-based cloud computing service provided by Google, introduced two innovative AI-driven solutions. These solutions, the Target and Lead Identification Suite and the Multiomics Suite are designed to improve drug discovery and precision medicine across biotech, pharmaceutical, and public sector organizations. The Target and Lead Identification Suite helps researchers understand amino acid functions and predict protein structures, while the Multiomics Suite speeds up the analysis and understanding of genomic data, simplifying the development of personalized treatments.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Drug Discovery Market? Recursion Pharmaceuticals Acquires Cyclica And Valence To Bolster AI-Driven Drug Discovery Capabilities

In May 2023, Recursion Pharmaceuticals, a US-based clinical-stage TechBio company, acquired Cyclica and Valence for $40 million and $47.5 million. The acquisitions of Cyclica and Valence by Recursion have significantly enhanced its drug discovery capabilities through advanced technologies. This positions Recursion as a leading hub for top-tier professionals in ML and AI, poised to innovate and drive the future of drug discovery. Cyclica Inc. is a Canada-based biotechnology company specializing in data-driven drug discovery, biophysics, and artificial intelligence to develop predictive analytics software. Valence Labs is a Canada-based AI-driven research organization that focuses on advancing the frontier of AI in drug discovery.

What Is The Regional Outlook For The Global Generative Artificial Intelligence (AI) In Drug Discovery Market?

North America was the largest region in the generative AI in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Generative Artificial Intelligence (AI) In Drug Discovery Market?

The generative AI in drug discovery market includes revenues earned by entities by providing services such as molecule generation, optimization, virtual screening, predictive modeling, de novo drug design, and consulting support. The market value includes the value of related goods sold by the service provider or included within the service offering. The generative AI in drug discovery market also includes sales of quantum computers, high-performance computing (HPC) clusters, tensor processing units, graphics processing units, and preclinical development tools. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Generative Artificial Intelligence (AI) In Drug Discovery Industry?

The generative artificial intelligence (ai) in drug discovery market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the generative artificial intelligence (ai) in drug discovery industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Generative Artificial Intelligence (AI) In Drug Discovery Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $0.25 billion
Revenue Forecast In 2034 $0.7 billion
Growth Rate CAGR of 28.8% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Type: Small Molecule, Large Molecule
2) By Technology: Deep Learning, Machine Learning, Reinforcement Learning, Molecular Docking, Quantum Computing
3) By End-User: Pharmaceutical And Biotechnology Companies, Academic And Research Institutions, Contract Research Organizations (CROs), Other End-Users Subsegments: 1) By Small Molecule: Drug Design And Optimization, Lead Discovery And Identification, Toxicology Prediction, Molecular Property Prediction, ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction
2) By Large Molecule: Protein Structure Prediction, Antibody Design, Biologics Optimization, Peptide Design, Biopharmaceutical Discovery And Optimization
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrödinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Generative Artificial Intelligence (AI) In Drug Discovery Market Characteristics

3. Generative Artificial Intelligence (AI) In Drug Discovery Market Trends And Strategies

4. Generative Artificial Intelligence (AI) In Drug Discovery Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Generative Artificial Intelligence (AI) In Drug Discovery Growth Analysis And Strategic Analysis Framework

5.1. Global Generative Artificial Intelligence (AI) In Drug Discovery PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Growth Rate Analysis

5.4. Global Generative Artificial Intelligence (AI) In Drug Discovery Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Generative Artificial Intelligence (AI) In Drug Discovery Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Generative Artificial Intelligence (AI) In Drug Discovery Total Addressable Market (TAM)

6. Generative Artificial Intelligence (AI) In Drug Discovery Market Segmentation

6.1. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Small Molecule

Large Molecule

6.2. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Deep Learning

Machine Learning

Reinforcement Learning

Molecular Docking

Quantum Computing

6.3. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Pharmaceutical And Biotechnology Companies

Academic And Research Institutions

Contract Research Organizations (CROs)

Other End-Users

6.4. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Drug Design and Optimization

Lead Discovery and Identification

Toxicology Prediction

Molecular Property Prediction

ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Prediction

6.5. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Protein Structure Prediction

Antibody Design

Biologics Optimization

Peptide Design

Biopharmaceutical Discovery and Optimization

7. Generative Artificial Intelligence (AI) In Drug Discovery Market Regional And Country Analysis

7.1. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market

8.1. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Generative Artificial Intelligence (AI) In Drug Discovery Market

9.1. China Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

9.2. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Generative Artificial Intelligence (AI) In Drug Discovery Market

10.1. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market

11.1. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

11.2. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market

12.1. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market

13.1. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market

14.1. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

14.2. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market

15.1. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

15.2. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Generative Artificial Intelligence (AI) In Drug Discovery Market

16.1. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market

17.1. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Generative Artificial Intelligence (AI) In Drug Discovery Market

18.1. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market

19.1. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market

20.1. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market

21.1. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

21.2. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market

22.1. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Generative Artificial Intelligence (AI) In Drug Discovery Market

23.1. North America Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

23.2. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Generative Artificial Intelligence (AI) In Drug Discovery Market

24.1. USA Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

24.2. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market

25.1. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

25.2. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Generative Artificial Intelligence (AI) In Drug Discovery Market

26.1. South America Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

26.2. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market

27.1. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market

28.1. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

28.2. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market

29.1. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market Overview

29.2. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape And Company Profiles

30.1. Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Landscape

30.2. Generative Artificial Intelligence (AI) In Drug Discovery Market Company Profiles

30.2.1. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

30.2.2. NVIDIA Corporation Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis

30.2.4. IBM Research Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Schrödinger Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Generative Artificial Intelligence (AI) In Drug Discovery Market Other Major And Innovative Companies

31.1. Valo Health

31.2. BenevolentAI

31.3. XtalPi Inc.

31.4. Insilico Medicine Inc.

31.5. Recursion Pharmaceuticals Inc.

31.6. Exscientia

31.7. Atomwise Inc.

31.8. InveniAI LLC

31.9. Healx

31.10. Aitia

31.11. Cloud Pharmaceuticals Inc.

31.12. Optibrium

31.13. Aiforia

31.14. BioSymetrics Inc.

31.15. Collaborations Pharmaceuticals Inc.

32. Global Generative Artificial Intelligence (AI) In Drug Discovery Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Generative Artificial Intelligence (AI) In Drug Discovery Market

34. Recent Developments In The Generative Artificial Intelligence (AI) In Drug Discovery Market

35. Generative Artificial Intelligence (AI) In Drug Discovery Market High Potential Countries, Segments and Strategies

35.1 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Countries Offering Most New Opportunities

35.2 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Segments Offering Most New Opportunities

35.3 Generative Artificial Intelligence (AI) In Drug Discovery Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Bayer AG Financial Performance
  • Table 77: NVIDIA Corporation Financial Performance
  • Table 78: Merck KGaA Financial Performance
  • Table 79: IBM Research Financial Performance
  • Table 80: Schrödinger Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Small Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Sub-Segmentation Of Large Molecule, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Generative Artificial Intelligence (AI) In Drug Discovery Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Asia-Pacific, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: China, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: India, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Japan, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Australia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Indonesia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: South Korea, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: Western Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: UK, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: Germany, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: France, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Italy, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Spain, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Eastern Europe, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Russia, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: North America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: USA, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: Canada, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: South America, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Brazil, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Middle East, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Africa, Generative Artificial Intelligence (AI) In Drug Discovery Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Bayer AG Financial Performance
  • Figure 77: NVIDIA Corporation Financial Performance
  • Figure 78: Merck KGaA Financial Performance
  • Figure 79: IBM Research Financial Performance
  • Figure 80: Schrödinger Inc. Financial Performance

Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Read More About Next-Gen Healthcare Services : Market Forecast, Transformation, and Long-Term Trajectories

Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

Read More About Hospitals And Outpatient Care Centers Growth Trajectory: Key Forecasts and Strategic Insights

ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Read More About ICU Beds Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

Read More About Emerging Trends Redefining the ICU Beds Market Landscape: Innovative Products In Influenza Diagnostic Market Development

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

Read More About A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Read More About A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Read More About Explore future trends in the global pharma and biotech CRM software market. Understand market growth, drivers, and industry outlook through 2034.

Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Read More About Explore market drivers and forecast in the nasal spray influenza vaccine sector through 2025–2034.

Virtual Kitchen Global Market Report 2025 – By Component (Software, Services, Hardware, Other Components), By Application (Workplaces, Household, Schools, Other Applications), By End-User (Commercial Space, Residential, ...

View Report

Artificial Intelligence (AI) In Drug Discovery Global Market Report 2025 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecules, Large Molec...

View Report

Embedded Field-Programmable Gate Array (FPGA) Global Market Report 2025 – By Type (Electrically Erasable Programmable Read-only Memory, Antifuse, Static Random Access Memory, Other Types), By Technology (Very Large-Scale...

View Report

Synthetic Hormones Global Market Report 2025 – By Product Type (Steroid Hormones, Peptide Hormone, Amino Acid Derivatives, Other Product Types), By Route of Administration (Oral, Nasal, Topical, Intravenous), By Applicat...

View Report

N-Methyl-2-Pyrrolidone (NMP) Global Market Report 2025 – By Type (Recycled, Fresh), By Purity (99.90%, 99.50%, Other Purities), By End User (Paints and Coatings, Electronics, Automotive, Chemicals, Pharmaceuticals, Agroc...

View Report

Energy Efficient Devices Global Market Report 2025 – By Component (Hardware, Software, Services), By System Type (Industrial Energy Management Systems (IEMS), Building Energy Management Systems (BEMS), Home Energy Manage...

View Report

Endotoxin Testing Global Market Report 2025 – By Test Type (LAL (Limulus Amebocyte Lysate) Test, Chromogenic Tests, Turbidimetric Tests, Gel Clot Tests, MAT Test, Rabbit Pyrogen Test, Recombinant Factor C (rFC) Assay), B...

View Report

Frequently Asked Questions

Generative AI in drug discovery involves using advanced machine learning, especially generative models, to create and identify new pharmaceutical compounds. These AI systems analyze extensive data, including chemical properties, biological activity, and existing drug information to predict and generate novel molecules with potential therapeutic benefits. The primary aim of generative AI in drug discovery is to accelerate the creation and identification of novel pharmaceutical compounds with potential therapeutic effects, optimizing the drug development process by leveraging extensive data to predict and generate new molecules efficiently. For further insights on this market, request a sample here

The market major growth driver - Rising Clinical Trials on the Generative AI in Drug Discovery Market. For further insights on this market, request a sample here

The generative artificial intelligence (AI) in drug discovery market size has grown exponentially in recent years. It will grow from $0.19 billion in 2024 to $0.25 billion in 2025 at a compound annual growth rate (CAGR) of 30.6%. The growth in the historic period can be attributed to rising prevalence of chronic diseases, development of new drug discoveries and clinical trials, supporting AI integration into healthcare and drug development, growing biotech industries and increasing governmental support. The generative artificial intelligence (AI) in drug discovery market size is expected to see exponential growth in the next few years. It will grow to " $0.7 billion in 2029 at a compound annual growth rate (CAGR) of 28.8%. The growth in the forecast period can be attributed to demand for cost-effective drug discovery drives adoption of generative AI, growing collaborations among market players, increasing computational power, integration of generative AI with other emerging technologies and rapid drug development. Major trends in the forecast period include advanced technologies, integration of generative AI with experimental biology, high-throughput screening for accelerated drug discovery pipelines, development of AI-driven platforms for drug repurposing and rising adoption of cloud-based AI solutions for collaborative drug discovery efforts. For further insights on this market, request a sample here

The generative artificial intelligence (AI) in drug discoverymarket covered in this report is segmented –
1) By Type: Small Molecule; Large Molecule
2) By Technology: Deep Learning; Machine Learning; Reinforcement Learning; Molecular Docking; Quantum Computing
3) By End-User: Pharmaceutical And Biotechnology Companies; Academic And Research Institutions; Contract Research Organizations (CROs); Other End-Users Subsegments:
1) By Small Molecule: Drug Design And Optimization; Lead Discovery And Identification; Toxicology Prediction; Molecular Property Prediction; ADMET (Absorption, Distribution, Metabolism, Excretion, And Toxicity) Prediction
2) By Large Molecule: Protein Structure Prediction; Antibody Design; Biologics Optimization; Peptide Design; Biopharmaceutical Discovery And Optimization For further insights on this market, request a sample here

North America was the largest region in the generative AI in drug discovery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the generative artificial intelligence (AI) in drug discovery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the generative artificial intelligence (AI) in drug discovery market are Bayer AG, NVIDIA Corporation, Merck KGaA, IBM Research, Schrödinger Inc., Valo Health, BenevolentAI, XtalPi Inc., Insilico Medicine Inc., Recursion Pharmaceuticals Inc., Exscientia, Atomwise Inc., InveniAI LLC, Healx, Aitia, Cloud Pharmaceuticals Inc., Optibrium, Aiforia, BioSymetrics Inc., Collaborations Pharmaceuticals Inc., MAbSilico, Reverie Labs, Standigm Inc., DeepMatter Group Limited, Variational AI Inc. For further insights on this market, request a sample here.

Major trends in this market include Advanced AI Solutions To Revolutionize Drug Discovery And Precision Medicine. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Generative Artificial Intelligence (AI) In Drug Discovery Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon